Founders: Geoffrey von Maltzahn (CEO), John Kim, Chris Fussell, Andy Beam, Rafael Gómez-Bombarelli, John Gregoire, Ben Kompa, Alex Sneider, Josh Waitzkin, Noubar Afeyan
Launched: 2023
Headquarters: Cambridge, Massachusetts
Funding: $550 million
Valuation: $1.3 billion
Key Technologies: Artificial intelligence, deep neural networks/deep learning, generative AI, machine learning, robotics
Industry: Biotech
Previous appearances on Disruptor 50 list: 0
Lila Sciences was founded in 2023 by Flagship Pioneering, the same incubator that launched 2015 No. 1 CNBC Disruptor 50 company Moderna. Lila aims to build what it calls "the world's first scientific superintelligence platform," an AI-driven system that can generate hypotheses and then design and run experiments that it learns from in real time.
In addition to its superintelligence platform, Lila is building out AI Science Factories — automated robotic labs that can continuously run experiments driven by Lila's AI models. And while that sounds more like science fiction than reality, Lila has already demonstrated early proof of concept, generating novel antibodies and developing new carbon capturing materials in its lab much quicker than would be possible using traditional research models.
The result is a platform with the potential to disrupt the very process of scientific discovery, and usher in a new era of rapid innovation across a broad set of industries. Lila says its platform is designed to work with companies in life, chemistry, and materials science spaces, with potential applications for drug discovery, energy and defense systems, and semiconductor and advanced material designs.
Investors have taken notice. In October, Lila raised $115 million in an extension round from investors that included Nvidia's venture arm. It was part of a $350 million Series A round that valued the company at more than $1.3 billion. In all, Lila has raised $550 million. And the company is putting that money to work, building out a 235,000-square-foot facility near Boston with plans to expand to San Francisco and London.
As with all things AI, there are questions around whether the hype surrounding Lila is running ahead of reality. Many AI platforms have struggled to show that they can consistently produce better results than traditional research models. While Lila has bold ideas, it also has a team that has shown it can execute — led by co-founder and CEO Geoffrey von Maltzahn, who has launched several biotech and AI startups, and bolstered by executives with a long track record of success in the biotech, AI and financial spaces.
Sign up for our weekly, original newsletter that goes beyond the annual Disruptor 50 list, offering a closer look at the most promising venture-backed companies.
